Sunshine Biopharma (SBFM) P/E (2010 - 2026)
Sunshine Biopharma (SBFM) P/E from Dec 31, 2010 to Jun 3, 2026. The TTM Sunshine Biopharma (SBFM) P/E is -2.09. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Sunshine Biopharma (SBFM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.09 | -75.26% |
| 2025 | -8.46 | -37.27% |
| 2024 | -13.49 | -94.15% |
| 2023 | -230.48 | -99.25% |
| 2022 | -30.82K | +129438.65% |
| 2021 | -23.79 | +126.95% |
| 2020 | -10.48 | +3193.63% |
| 2019 | -0.32 | -96.31% |
| 2018 | -8.64 | -97.17% |
| 2017 | -305.27 | +197.50% |
| 2016 | -102.61 | -53.99% |
| 2015 | -223.01 | +17.65% |
| 2014 | -189.55 | -72.64% |
| 2013 | -692.89 | -85.36% |
| 2012 | -4.73K | -910.22% |
| 2011 | 584.25 | -63.39% |
| 2010 | 1.60K | N/A |
Comparison Sunshine Biopharma (SBFM) P/E with competitors
Sunshine Biopharma (SBFM) P/E is -2.09.